Lu ShuXuan, Xu Jin, Lu HongYi, Chi WanLei
Otolaryngological Department, TongDe Hospital of Zhejiang Province, Hangzhou, China.
Evid Based Complement Alternat Med. 2022 Aug 26;2022:9516029. doi: 10.1155/2022/9516029. eCollection 2022.
This study aims to evaluate the effectiveness of Balloon Eustachian tuboplasty (BET) and grommet insertion in patients having chronic suppurative otitis media combined with eustachian tube dysfunction (CSOM-ETD).
We evaluated the data of CSOM-ETD patients ( = 96) from January 2019 to January 2021, who were divided into the following groups: 48 cases underwent BET (BET group) and 48 cases underwent BET plus Grommet insertion (BET + Grommet group). The air-bone gap (ABG), Eustachian Tube Dysfunction Questionnaire (ETDQ-7) score, Eustachian tube inflammation scale, Chronic Otitis Media Outcome Test 15 (COMOT-15), Valsalva maneuver, and patient satisfaction were evaluated after surgery.
The postoperative ABG in the BET + Grommet group was better than that in the BET. In addition, the ABG was improved obviously in the BET + Grommet group at 6 and 12 months after the corresponding surgery. Moreover, the Eustachian tube inflammation scale, ETDQ-7, and COMOT-15 scores were reduced after the treatment with the combination of BET and Grommet insertion at 6 and 12 months. The postoperative ETDQ-7 score, Eustachian tube inflammation scale, and COMOT-15 score were lower in the BET + Grommet group than that in the BET group. The percentage of patients who could perform a positive Valsalva maneuver was significantly higher in the BET + Grommet group than that in the BET group at 6 months and 12 months after surgery with increased patient satisfaction.
Our results demonstrate that BET plus Grommet insertion showed better treatment efficacy for patients with CSOM-ETD than BET alone via improving the Eustachian tube function hearing outcome and quality of life with less Eustachian tube inflammation.
本研究旨在评估球囊咽鼓管成形术(BET)和鼓膜置管术对慢性化脓性中耳炎合并咽鼓管功能障碍(CSOM-ETD)患者的疗效。
我们评估了2019年1月至2021年1月期间CSOM-ETD患者(n = 96)的数据,这些患者被分为以下几组:48例行BET手术(BET组),48例行BET联合鼓膜置管术(BET + 鼓膜置管组)。术后评估气骨导差(ABG)、咽鼓管功能障碍问卷(ETDQ-7)评分、咽鼓管炎症量表、慢性中耳炎结果测试15(COMOT-15)、瓦尔萨尔瓦动作及患者满意度。
BET + 鼓膜置管组术后ABG优于BET组。此外,BET + 鼓膜置管组在相应手术后6个月和12个月时ABG明显改善。而且,在6个月和12个月时,BET联合鼓膜置管术治疗后咽鼓管炎症量表、ETDQ-7和COMOT-15评分降低。BET + 鼓膜置管组术后ETDQ-7评分、咽鼓管炎症量表和COMOT-15评分低于BET组。术后6个月和12个月时,BET + 鼓膜置管组能进行阳性瓦尔萨尔瓦动作的患者百分比显著高于BET组,患者满意度提高。
我们的结果表明,对于CSOM-ETD患者,BET联合鼓膜置管术比单纯BET治疗效果更好,可通过改善咽鼓管功能、听力结果和生活质量,减少咽鼓管炎症。